Liu S, Lan XB, Tian MM, Zhu CH, et al. Targeting the chemokine ligand 2-chemokine receptor 2 axis provides the possibility of immunotherapy in chronic pain. Eur J Pharmacol 2023 Mar 10:175646. doi: 10.1016/j.ejphar.2023.175646.
PMID: 36907261